Silver Sulfadiazene
Pricing Report NDC 0591-0810-55

Latest NADAC: $0.17467 per GM · Effective Jul 18, 2018 · Est. package price $8.73 (50 GM)
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Silver Sulfadiazene (NDC 0591-0810-55) is $0.17467 per GM. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jul 18, 2018.

As a provided by Actavis Pharma, Inc., this medication is distributed in a 50 g in 1 JAR configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.17467
Per GM

Pricing Unit
Per GM Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Jul 18, 2018
Billable Units
50 GM
Estimated Package Price
$8.73
Data Status
As of Aug 01, 2018
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
0591-0810-55
Description
50 g in 1 JAR
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $0.08584 to $0.26016 per GM. Over this 4 years and 7 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.0858 - $0.1169
Market Volatility
36.13% Variance
Latest Trend
0.09%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Jul 18, 2018 $0.08739 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jul 18, 2018 $0.17467 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jun 20, 2018 $0.08747 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jun 20, 2018 $0.17467 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jun 20, 2018 $0.21566 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jun 20, 2018 $0.16929 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
May 23, 2018 $0.08967 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
May 23, 2018 $0.17817 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
May 23, 2018 $0.22604 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
May 23, 2018 $0.17750 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Apr 18, 2018 $0.08584 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Apr 18, 2018 $0.16621 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026